“…4 Recently, salvage cryoablation (SC) has emerged as a less-invasive alternative with lower perioperative morbidity profile. [5][6][7] However, with cancer recurrence after SC ranging from 37%-49%, [5][6][7] several investigators have attempted to identify predictors of SC failure to improve patient selection. Preradiation oncologic parameters including Gleason score, prostate-specific antigen (PSA), and clinical stage, 8,9 as well as presalvage parameters such as Gleason score, PSA, 10 and PSA doubling time, 11 were some factors found to correlate with cancer recurrence after SC.…”